Ascendis Pharma A/SASNDNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+27.4%
5Y CAGR+42.2%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+27.4%/yr
vs +71.3%/yr prior
5Y CAGR
+42.2%/yr
Recent deceleration
Acceleration
-43.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
5.8x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $446.25M | +56.8% |
| 2024 | $284.55M | +10.0% |
| 2023 | $258.79M | +19.9% |
| 2022 | $215.85M | +34.8% |
| 2021 | $160.18M | +108.9% |
| 2020 | $76.67M | +58.2% |
| 2019 | $48.47M | +93.5% |
| 2018 | $25.06M | +85.9% |
| 2017 | $13.48M | +17.2% |
| 2016 | $11.50M | - |